Cargando…

Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase – Design, synthesis and biological evaluation

The complex and multifactorial nature of neuropsychiatric diseases demands multi-target drugs that can intervene with various sub-pathologies underlying disease progression. Targeting the impairments in cholinergic and glutamatergic neurotransmissions with small molecules has been suggested as one o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Remya, Chandran, Dileep, K.V., Koti Reddy, Eeda, Mantosh, Kumar, Lakshmi, Kesavan, Sarah Jacob, Reena, Sajith, Ayyiliyath M., Jayadevi Variyar, E., Anwar, Shaik, Zhang, Kam Y.J., Sadasivan, C., Omkumar, R.V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Research Network of Computational and Structural Biotechnology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379669/ https://www.ncbi.nlm.nih.gov/pubmed/34471497 http://dx.doi.org/10.1016/j.csbj.2021.07.041

Ejemplares similares

Flavanone Glycosides as Acetylcholinesterase Inhibitors: Computational and Experimental Evidence
por: Remya, C., et al.
Publicado: (2014)

Neuroactive Multifunctional Tacrine Congeners with Cholinesterase, Anti-Amyloid Aggregation and Neuroprotective Properties
por: Kozurkova, Maria, et al.
Publicado: (2011)

Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors
por: Svobodova, Barbora, et al.
Publicado: (2019)

QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease Therapy
por: Ramos, Eva, et al.
Publicado: (2019)

Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease
por: Chen, Yao, et al.
Publicado: (2017)

Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities
por: Chrienova, Zofia, et al.
Publicado: (2022)

Structural, harmonic force field and vibrational studies of cholinesterase inhibitor tacrine used for treatment of Alzheimer's disease
por: Sundius, Tom, et al.
Publicado: (2023)

Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease
por: Zhu, Jie, et al.
Publicado: (2018)

Design, synthesis and evaluation of OA-tacrine hybrids as cholinesterase inhibitors with low neurotoxicity and hepatotoxicity against Alzheimer’s disease
por: Yang, Huali, et al.
Publicado: (2023)

Lipoxygenase inhibitory synthetic derivatives of methyl gallate regulate gene expressions of COX-2 and cytokines to reduce animal model arthritis
por: Sharanya, C.S., et al.
Publicado: (2023)

Protection of α-CaMKII from Dephosphorylation by GluN2B Subunit of NMDA Receptor Is Abolished by Mutation of Glu(96) or His(282) of α-CaMKII
por: Mayadevi, Madhavan, et al.
Publicado: (2016)

Therapeutic Potential of Multifunctional Tacrine Analogues
por: Przybyłowska, Maja, et al.
Publicado: (2019)

Conjugates of Tacrine with Salicylamide as Promising Multitarget Agents for Alzheimer's Disease
por: Grishchenko, Maria V., et al.
Publicado: (2022)

Tacrine Derivatives in Neurological Disorders: Focus on Molecular Mechanisms and Neurotherapeutic Potential
por: Mitra, Saikat, et al.
Publicado: (2022)

QSAR analysis on tacrine-related acetylcholinesterase inhibitors
por: Wong, Kai Y, et al.
Publicado: (2014)

Tacrine-Based Hybrids: Past, Present, and Future
por: Bubley, Anna, et al.
Publicado: (2023)

Formulation, Characterization and Evaluation against SH-SY5Y Cells of New Tacrine and Tacrine-MAP Loaded with Lipid Nanoparticles
por: Silva, Sara, et al.
Publicado: (2020)

miR-146a and miR-200b alter cognition by targeting NMDA receptor subunits
por: Gunasekaran, Sowmya, et al.
Publicado: (2022)

Towards novel tacrine analogues: Pd(dppf)Cl(2)·CH(2)Cl(2) catalyzed improved synthesis, in silico docking and hepatotoxicity studies
por: Babu, Aravinda, et al.
Publicado: (2022)

Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer’s Disease
por: Makhaeva, Galina F., et al.
Publicado: (2023)

Calcium/Calmodulin Dependent Protein Kinase II Bound to NMDA Receptor 2B Subunit Exhibits Increased ATP Affinity and Attenuated Dephosphorylation
por: Cheriyan, John, et al.
Publicado: (2011)

Development of tacrine clusters as positively cooperative systems for the inhibition of acetylcholinesterase
por: Evangelista, Tereza Cristina Santos, et al.
Publicado: (2021)

Mechanism of Tacrine Block at Adult Human Muscle Nicotinic Acetylcholine Receptors
por: Prince, Richard J., et al.
Publicado: (2002)

The Investigation of Structure-Activity Relationships of Tacrine Analogues: Electronic-Topological Method
por: Saracoglu, Murat, et al.
Publicado: (2008)

New Tacrine Analogs as Acetylcholinesterase Inhibitors — Theoretical Study with Chemometric Analysis
por: Szymański, Paweł, et al.
Publicado: (2013)

Effect of Donepezil, Tacrine, Galantamine and Rivastigmine on Acetylcholinesterase Inhibition in Dugesia tigrina
por: Bezerra da Silva, Cristiane, et al.
Publicado: (2016)

In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers
por: Janockova, Jana, et al.
Publicado: (2019)

Model Amphipathic Peptide Coupled with Tacrine to Improve Its Antiproliferative Activity
por: Silva, Sara, et al.
Publicado: (2020)

Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers
por: Vaaland, I. Caroline, et al.
Publicado: (2022)

Electroacupuncture at PC6 or ST36 Influences the Effect of Tacrine on the Motility of Esophagus
por: Wang, Chi, et al.
Publicado: (2014)

Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer’s disease
por: Wu, Wen-Yu, et al.
Publicado: (2017)

Tin (IV) Chloride-Promoted One-Pot Synthesis of Novel Tacrine Analogues
por: Hu, Huanan, et al.
Publicado: (2011)

Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
por: Dgachi, Youssef, et al.
Publicado: (2018)

New Multifunctional Agents for Potential Alzheimer’s Disease Treatment Based on Tacrine Conjugates with 2-Arylhydrazinylidene-1,3-Diketones
por: Elkina, Natalia A., et al.
Publicado: (2022)

Analysis of Adverse Events of Cholinesterase Inhibitors and NMDA Receptor Antagonists on Arrhythmias Using the Japanese Adverse Drug Event Report Database
por: Kobayashi, Shotaro, et al.
Publicado: (2023)

Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis
por: Galdeano, Carles, et al.
Publicado: (2018)

Structural and vibrational characterization of di-hydrated hydrochloride tacrine combining DFT with SQMFF approach
por: Sundius, Tom, et al.
Publicado: (2023)

Cholinesterase Research
por: Korabecny, Jan, et al.
Publicado: (2021)

Role of Ca(2+)/Calmodulin-Dependent Protein Kinase Type II in Mediating Function and Dysfunction at Glutamatergic Synapses
por: Mohanan, Archana G., et al.
Publicado: (2022)

Neuroprotective effects of bis(7)-tacrine against glutamate-induced retinal ganglion cells damage
por: Fang, Jia Hua, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8skvps1o54v55novj3l32kj0uu